Skip to content
10-Q

Quarterly Report

BIOSCIENCE NEUTRACEUTICALS, INC.

0001640334-18-002087

← back to feed
Filed
Nov 8, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Oct 23, 2018 9.7M sh
Short Term Debt Q2 2018 · Jun 30, 2018 $3.96K
Current Liabilities Q2 2018 · Jun 30, 2018 $173K
Current Liabilities Q2 2018 · Dec 31, 2017 $134.23K
Total Liabilities Q2 2018 · Jun 30, 2018 $176.95K
Total Liabilities Q2 2018 · Dec 31, 2017 $134.23K
Current Assets Q2 2018 · Jun 30, 2018 $8.66K
Current Assets Q2 2018 · Dec 31, 2017 $4.69K
Total Assets Q2 2018 · Jun 30, 2018 $8.66K
Total Assets Q2 2018 · Dec 31, 2017 $4.69K
Sga Expense Q2 2018 · Jun 30, 2018 $2.28K
Sga Expense Q2 2018 · Jun 30, 2018 $4.47K
Sga Expense Q2 2018 · Jun 30, 2017 $1.23K
Gross Profit Q2 2018 · Jun 30, 2018 $539
Gross Profit Q2 2018 · Jun 30, 2018 −$1.93K
Cost Of Revenue Q2 2018 · Jun 30, 2018 $1.64K
Cost Of Revenue Q2 2018 · Jun 30, 2018 $6.4K
Revenue Q2 2018 · Jun 30, 2018 $2.18K
Revenue Q2 2018 · Jun 30, 2018 $4.47K
Operating Cash Flow Q2 2018 · Jun 30, 2017 −$14.58K
Net Income Q2 2018 · Jun 30, 2017 −$1.75K
Net Income Q2 2018 · Jun 30, 2017 −$5.48K
Operating Income Q2 2018 · Jun 30, 2017 −$1.75K
Operating Income Q2 2018 · Jun 30, 2017 −$5.48K